Ping Chi

16.2k citations

145 papers · 5.9k indexed · 4 hit papers · h-index 35

Impact in

Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
Pulmonary and Respiratory Medicine top 1%
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes

Papers in ⓘ

Gastroenterology 46
- Gastrointestinal Tumor Research and Treatment 46
Pulmonary and Respiratory Medicine 75
- Sarcoma Diagnosis and Treatment 45
- Gastric Cancer Management and Outcomes 24

Co-authors: C. David Allis (4 shared papers)Gang Greg Wang (3 shared papers)Paul Greengard (5 shared papers)Timothy A. Ryan (5 shared papers)Cristina R. Antonescu (41 shared papers)Yu Chen (12 shared papers)Ciara M. Kelly (27 shared papers)William D. Tap (47 shared papers)
Journals: Journal of Clinical Oncology (33 papers)Annals of Oncology (10 papers)Clinical Cancer Research (5 papers)Genes Chromosomes and Cancer (5 papers)Cancer Research (4 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Ping Chi

137 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer 2022 · 141 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Communications
2021 Journal of Hematology & Oncology
2020 The Lancet Oncology
2010 Nature reviews. Cancer

Peers

Countries citing papers authored by Ping Chi

Since Specialization

Citations

This map shows the geographic impact of Ping Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Chi more than expected).

Fields of papers citing papers by Ping Chi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Chi. The network helps show where Ping Chi may publish in the future.

Co-authors

The 25 scholars most cited alongside Ping Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ping Chi Line = papers co-authored together Ping Chi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers Nature reviews. Cancer ·Ping Chi, C. David Allis, Gang Greg Wang Hit paper breakdown →	2010	842
2	Synapsin dispersion and reclustering during synaptic activity Nature Neuroscience ·Ping Chi, Paul Greengard, Timothy A. Ryan	2001	299
3	Chromatin remodeling and cancer, part I: covalent histone modifications Trends in Molecular Medicine ·Gang Greg Wang, C. David Allis, Ping Chi	2007	293
4	Synaptic Vesicle Mobilization Is Regulated by Distinct Synapsin I Phosphorylation Pathways at Different Frequencies Neuron ·Ping Chi, Paul Greengard, Timothy A. Ryan	2003	273
5	Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial The Lancet Oncology ·Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren Hit paper breakdown →	2020	251
6	ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours Nature ·Ping Chi, Yu Chen, Lei Zhang, Xingyi Guo, John Wongvipat, Tambudzai Shamu, Jonathan A. Fletcher, Scott Dewell, Robert G. Maki, Deyou Zheng, Cristina R. Antonescu, C. David Allis, Charles L. Sawyers	2010	243
7	Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib JAMA Oncology ·Mark A. Dickson, Gary K. Schwartz, Mary Louise Keohan, Sandra P. D’Angelo, Mrinal M. Gounder, Ping Chi, Cristina R. Antonescu, Jonathan Landa, Li‐Xuan Qin, Aimeé M. Crago, Samuel Singer, Andrew Koff, William D. Tap	2016	220
8	Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma Nature Genetics ·Amanda R. Moore, Emilie Ceraudo, Jessica Sher, Youxin Guan, Alexander N. Shoushtari, Matthew T. Chang, Jenny Q. Zhang, Edward Walczak, Manija A. Kazmi, Barry S. Taylor, Thomas Huber, Ping Chi, Thomas P. Sakmar, Yu Chen	2016	214
9	Hormone Activity of Hydroxylated Polybrominated Diphenyl Ethers on Human Thyroid Receptor-β: In Vitro and In Silico Investigations Environmental Health Perspectives ·Fei Li, Qing Xie, Xuehua Li, Na Li, Ping Chi, Jingwen Chen, Zijian Wang, Ce Hao	2009	201
10	ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss Nature Medicine ·Yu Chen, Ping Chi, Shira Rockowitz, Phillip J. Iaquinta, Tambudzai Shamu, Shipra Shukla, Dong Gao, Inna Sirota, Brett S. Carver, John Wongvipat, Howard I. Scher, Deyou Zheng, Charles L. Sawyers	2013	196
11	Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST The American Journal of Surgical Pathology ·Carlos Prieto‐Granada, Thomas Wiesner, Jane L. Messina, Achim A. Jungbluth, Ping Chi, Cristina R. Antonescu	2015	189
12	Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling Trends in Molecular Medicine ·Gang Greg Wang, C. David Allis, Ping Chi	2007	180
13	The management of metastatic GIST: current standard and investigational therapeutics Journal of Hematology & Oncology ·Ciara M. Kelly, L. Gutiérrez Sainz, Ping Chi Hit paper breakdown →	2021	144
14	Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer Nature Communications ·Andrea López, Denis E. Reyna, Nadege Gitego, Felix Kopp, Hua Zhou, Miguel A. Miranda-Román, Lars Ulrik Nordstrøm, Swathi-Rao Narayanagari, Ping Chi, Eduardo Vilar, Aristotelis Tsirigos, Evripidis Gavathiotis Hit paper breakdown →	2022	141
15	Inhibition of Cellular Cdk2 Activity Blocks Human Cytomegalovirus Replication Virology ·Wade A. Bresnahan, István Boldogh, Ping Chi, E. Aubrey Thompson, Thomas Albrecht	1997	125
16	Regulation of Neurotransmitter Release by Synapsin III Journal of Neuroscience ·Jian Feng, Ping Chi, Thomas A. Blanpied, Yimei Xu, Ana Marı́a Magariños, Adriana Ferreira, Reisuke H. Takahashi, Hung‐Teh Kao, Bruce S. McEwen, Timothy A. Ryan, George J Augustine, Paul Greengard	2002	125
17	Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab Clinical Cancer Research ·Sandra P. D’Angelo, Alexander N. Shoushtari, Mary Louise Keohan, Mark A. Dickson, Mrinal M. Gounder, Ping Chi, Jennifer K. Loo, Leigh Gaffney, Lee Schneider, Zarine Patel, Joseph P. Erinjeri, Mark J. Bluth, Ana Sjoberg, Howard Streicher, Naoko Takebe, Li‐Xuan Qin, Cristina R. Antonescu, Ronald P. DeMatteo, Richard D. Carvajal, William D. Tap	2016	98
18	Clinical and Morphologic Characteristics of MEK Inhibitor–Associated Retinopathy Ophthalmology ·Jasmine H. Francis, Larissa A. Habib, David H. Abramson, Lawrence A. Yannuzzi, M. Heinemann, Mrinal M. Gounder, Rachel N. Grisham, Michael A. Postow, Alexander N. Shoushtari, Ping Chi, Neil H. Segal, Rona Yaeger, Alan L. Ho, Paul B. Chapman, Federica Catalanotti	2017	94
19	Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth Cancer Discovery ·Leili Ran, Inna Sirota, Zhen Cao, Devan Murphy, Yuedan Chen, Shipra Shukla, Yuanyuan Xie, Michael C. Kaufmann, Dong Gao, Sinan Zhu, Ferdinando Rossi, John Wongvipat, Takahiro Taguchi, William D. Tap, Ingo K. Mellinghoff, Peter Besmer, Cristina R. Antonescu, Yu Chen, Ping Chi	2015	93
20	Roscovitine: a novel regulator of P/Q‐type calcium channels and transmitter release in central neurons The Journal of Physiology ·Zhen Yan, Ping Chi, James Bibb, Timothy A. Ryan, Paul Greengard	2002	89

About Ping Chi

Ping Chi is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine, Oncology, Neurology and Hematology, having authored 145 papers that have together received 5.9k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (46 papers), Sarcoma Diagnosis and Treatment (45 papers), Gastric Cancer Management and Outcomes (24 papers), Neurofibromatosis and Schwannoma Cases (15 papers), CAR-T cell therapy research (12 papers), Vascular Tumors and Angiosarcomas (10 papers), Gastrointestinal disorders and treatments (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Gastroenterology (924 citations), Pulmonary and Respiratory Medicine (1.8k citations), Molecular Biology (2.8k citations), Oncology (1.1k citations) and Neurology (552 citations). Ping Chi has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include C. David Allis, Gang Greg Wang, Paul Greengard, Timothy A. Ryan, Cristina R. Antonescu, Yu Chen, Ciara M. Kelly, William D. Tap, Mrinal M. Gounder and Sandra P. D’Angelo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Genes Chromosomes and Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact